References

  1. Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal tetanus. Lancet. 2007 Dec 8;370(9603):1947-59. PubMed | Google Scholar

  2. Khan R, Vandelaer J, Yakubu A, Raza AA, Zulu F. Maternal and neonatal tetanus elimination: from protecting women and newborns to protecting all. Int J Womens Health. 2015;7:171-80. PubMed | Google Scholar

  3. World Health Organization. Tetanus vaccines: WHO Position Paper - February 2017. Wkly Epidemiol Rec. 2017 Feb 10; 92(6):53-76. PubMed | Google Scholar

  4. Roper M, Wassilak S, Tiwari T, Orenstein W. Tetanus Toxoid. In: Plotkin S, Orenstein W, editors. Vaccines. 6. Philadelphia: W.B. Saunders; 2013. p. 746-72.

  5. Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010 Apr;39 Suppl 1:i102-9. PubMed | Google Scholar

  6. Blencowe H, Cousens S, Mullany LC, Lee AC, Kerber K, Wall S et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect. BMC Public Health. 2011 Apr 13;11 Suppl 3:S11. PubMed | Google Scholar

  7. United Nations Children Fund, United Nations Population Fund, World Health Organization. Achieving and sustaining Maternal and Neonatal Tetanus Elimination: Strategic Plan 2012-2015, Geneva, Switzerland: WHO; 2012. Accessed 2016 September 18.

  8. Khan AA, Zahidie A, Rabbani F. Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries-a systematic review. BMC Public Health. 2013 Apr 09;13:322. PubMed | Google Scholar

  9. Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de Bernis L et al. Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet. 2005 Mar 12-18;365(9463):977-88. PubMed | Google Scholar

  10. Galazka A, Birmingham M, Kurian M, Gasse F. Tetanus. In: Murray C, Lopez A, Mathers C, editors. The Global Epidemiology of Infectious Diseases Geneva: World Health Organization; 2004. p. 151–99.

  11. Vandelaer J, Birmingham M, Gasse F, Kurian M, Shaw C, Garnier S. Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine. 2003 Jul 28;21(24):3442-5. PubMed | Google Scholar

  12. United Nations Children Fund, World Health Organization, United Nations Population Fund. Maternal and Neontal Tetanus Elimination by 2005: Strategies for achieving and maintaining elimintion: UNICEF; 2000. Accessed 2016 October 26.

  13. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE et al. Global, regional and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015 Jan 31;385(9966):430-40. PubMed | Google Scholar

  14. World Health Organization. Maternal and Neonatal Tetanus (MNT) elimination: Progress towards global MNT elimination. 2016. Updated November 9, 2016; Cited 2016 December 18.

  15. World Health Organization. Global Vaccine Action Plan 2011-2020. 2013. Accessed 2016 December 18.

  16. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2016 global summary. 2016. Updated July 15, 2016; Accessed 2016 September 29.

  17. World Health Organization. Data, statistics and graphics 2016. Updated December 1, 2016; Accessed 2016 December 16.

  18. World Health Organization. Tetanus (neonatal) reported cases 2016. Updated December 1, 2016; Accessed 2016 November 11.

  19. World Health Organization. WHO-UNICEF estimates of DTP3 coverage 2016 . Updated July 15, 2016. cited 2016 September 18.

  20. World Health Organization. World Health Organization. WHO-UNICEF estimates of PAB coverage 2016. Updated July 15, 2016; Accessed 2016 September 16.

  21. World Health Organization. Second and subsequent doses of tetanus toxoid 2016. Updated December 1, 2016; Accessed 2016 September 18. Google Scholar

  22. Griffiths UK, Wolfson LJ, Quddus A, Younus M, Hafiz RA. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan. Bull World Health Organ. 2004 Sep;82(9):643-51. PubMed | Google Scholar

  23. Scobie HM, Mao B, Buth S, Wannemuehler KA, Sorensen C, Kannarath C et al. Tetanus Immunity among Women Aged 15 to 39 Years in Cambodia: a National Population-Based Serosurvey, 2012. Clin Vaccine Immunol. 2016 Jul;23(7):546-54. PubMed | Google Scholar

  24. World Health Organization. Protection-at-birth (PAB) method, Tunisia. Wkly Epidemiol Rec. 2000 Jun 23;75(25):203-6. PubMed | Google Scholar

  25. United Nations Population Division. World Population Prospects: The 2015 Revision, DVD Edition 2015. Accessed 2016 December 18. Google Scholar

  26. World Health Organization. Maternal and Neonatal Tetanus (MNT) elimination: Supplementary Immunization Activities MNTE 2016. Updated April 21, 2016; Accessed 2016 November 5.

  27. United Nations Children Fund. Skilled Attendance. 2016. Updated February 2016; Accessed 2016 September 18.

  28. World Health Organization. Maternal and Neonatal Tetanus (MNT) related publications and useful links 2016. Updated December 1, 2013; Accessed 2016 December 18. Google Scholar

  29. World Health Organization. SAGE meeting of October 2016. 2016. Accessed 2016 December 15. Google Scholar

  30. World Health Organization. Global and regional immunization profile: African Region. 2016. Updated November 18, 2016; Accessed 2016 December 19. Google Scholar

  31. World Health Organization. Report of the SAGE Working Group on Maternal and Neonatal Tetanus Elimination and Broader Tetanus Prevention. 2016. Accessed 2016 December 15. Google Scholar

  32. World Health Organization. Health service coverage data by WHO region. 2016. Updated May 18, 2016; Accessed 2016 November 3. PubMed | Google Scholar

  33. World Health Organization. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. 2003. Updated July 2008; Accessed 2016 December 18. Google Scholar

  34. World Health Organization. Expanded programme on immunization-estimating tetanus protection of women by serosurvey. Wkly Epidemiol Rec. 1996 Apr 19;71(16):117-24. PubMed | Google Scholar

  35. Deming MS, Roungou JB, Kristiansen M, Heron I, Yango A, Guenengafo A et al. Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. Bull World Health Organ. 2002;80(9):696-703. PubMed | Google Scholar

  36. Cutts FT, Hanson M. Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries. Trop Med Int Health. 2016 Sep;21(9):1086-98. PubMed | Google Scholar

  37. BBC. Kenya Catholic Church Tetanus Vaccine Fears 'unfounded'. 2014 (updated October 13, 2014; accessed 2016 December 18). Google Scholar

  38. World Health Organization. Assessment of neonatal tetanus elimination in Eritrea. Wkly Epidemiol Rec. 2004 Jun 11;79(24):222-7. PubMed | Google Scholar

  39. World Health Organization. Validation of maternal and neonatal tetanus elimination in Liberia, 2011. Wkly Epidemiol Rec. 2012 May 4;87(18):169-76. PubMed | Google Scholar

  40. World Health Organization. Validation of neonatal tetanus elimination in Burundi and the Comoros by a lot quality assurance cluster sampling survey, 1 October 2008- 30 September 2009. Wkly Epidemiol Rec. 2011 Jul 8;86(28):289-99. PubMed | Google Scholar

  41. World Health Organization. Validation of elimination: maternal and neonatal tetanus in Mozambique, 2010. Wkly Epidemiol Rec. 2011 Oct 28;86(44):481-8. PubMed | Google Scholar

  42. Scobie HM, Patel M, Martin D, Mkocha H, Njenga SM, Odiere MR, et al. Tetanus Immunity Gaps in Children 5-14 Years and Men ≥ 15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and Mozambique. Am J Trop Med Hyg. 2017 Feb 8;96(2):415-420. PubMed | Google Scholar

  43. D’Alois L SB, Millogo J, Diarra S, Plowman BA, Steinglass R. Impact of Delivery Technologies on Increased Access. TT-Uniject Report Mali. 2004. Updated March, 2004; Accessed 2016 December 18.

  44. World Health Organization. Maternal and neonatal tetanus elimination: validation survey in 4 States and 2 union territories in India, May 2015. Wkly Epidemiol Rec. 2015 Oct 30;90(44):589-608. PubMed | Google Scholar

  45. World Health Organization. Maternal and neonatal tetanus elimination: validation survey in 4 States in India, April 2013. Wkly Epidemiol Rec. 2014 May 2;89(18):177-88. PubMed | Google Scholar

  46. Vandelaer J, Partridge J, Suvedi BK. Process of neonatal tetanus elimination in Nepal. J Public Health (Oxf). 2009 Dec;31(4):561-5. PubMed | Google Scholar

  47. Vandelaer J, Olaniran M. Using a school-based approach to deliver immunization-global update. Vaccine. 2015 Jan 29;33(5):719-25. PubMed | Google Scholar

  48. Global Vaccine Alliance Initiative. New and underused vaccines support GAVI; 2016. Accessed 2016 December 20.

  49. Dalal S, Samuelson J, Reed J, Yakubu A, Ncube B, Baggaley R. Tetanus disease and deaths in men reveal need for vaccination. Bull World Health Organ. 2016 Aug 1;94(8):613-21. PubMed | Google Scholar

  50. Grund JM, Toledo C, Davis SM, Ridzon R, Moturi E, Scobie H, et al. Notes from the Field: Tetanus Cases After Voluntary Medical Male Circumcision for HIV Prevention--Eastern and Southern Africa, 2012-2015. Morb Mortal Wkly Rep. 2016 Jan 22;65(2):36-7. PubMed | Google Scholar

  51. Basta NE, Borrow R, Berthe A, Onwuchekwa U, Dembele AT, Almond R et al. Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali. Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S578-85. PubMed | Google Scholar

  52. Borrow R, Tang Y, Yakubu A, Kulkarni PS, LaForce FM. MenAfriVac as an Antitetanus Vaccine. Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S570-7. PubMed | Google Scholar